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Abstract
Background: Hepatitis B virus (HBV) infection is a blood borne infectious disease that affects the liver. Human
bone marrow mesenchymal stem cells (BMSCs) may serve as a cell source for adult stem cell transplantation in
liver repair. However, the susceptibility of human BMSCs to HBV infection is poorly understood. The aim of this
study was to investigate the infection and replication of HBV in cultures of human BMSCs.
Results: Human BMSCs were confirmed using flow cytometry. Intracellular HBV DNA was detected at d 2 after
infection and maintained at relatively high levels from d 6 to d 12. The maximal level of intracellular HBV DNA was
9.37 × 10
5 copies/mL. The extracellular HBV DNA was observed from d 3 to d 15, and the levels ranged from 3.792
×1 0
2 copies/mL to 4.067 × 10
5 copies/mL. HBsAg in the culture medium was detected from d 2 to d 16. HBeAg
secretion was positive from d 5 to d 13. HBcAg constantly showed positive signals in approximately 7%-20% of
BMSCs from 2 days after exposure. Intracellular HBV covalently closed circular DNA (cccDNA) could be detected as
early as 2 days postinfection, and strong signals were obtained with increasing time.
Conclusion: HBV can infect and replicate in human BMSCs. Human BMSCs may be a useful tool for investigating
HBV life-cycle and the mechanism of initial virus-cell interactions.
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Background
Hepatitis B is one of the most common infectious dis-
eases worldwide. It has been estimated that 2 billion
people have been infected with hepatitis B virus (HBV).
In addition, 360 million people have chronic HBV infec-
tion, and 0.6 million people die each year from HBV-
related liver disease or hepatocellular carcinoma [1].
Despite the existence of a preventative vaccine, HBV
represents a substantial threat to public health [1]. A
convenient in vitro assay for HBV natural infectivity is
currently unavailable, and the early steps of the viral life
cycle are not well understood. Primary human hepato-
cytes are susceptible to HBV [2,3]. However, the use of
this model is hampered by limited resources and the
technical difficulties that are associated with primary
hepatocyte cultures. In recent years, liver-related stem
cells have attracted intense attention due to their prolif-
erative capabilities and inherent characteristics. Previous
studies have shown that human bone marrow mesench-
ymal stem cells (BMSCs) can differentiate into func-
tional hepatocyte-like cells in vitro [4,5], and restore
liver function in animal models of liver failure [6,7].
However, the susceptibility of human BMSCs to HBV
infection is poorly understood. In the present investiga-
tion, we demonstrated for the first time that human
BMSCs fully supported the fastidious HBV infection,
replication, expression, and secretion. Human BMSCs
o f f e r san e wo p p o r t u n i t yf o rb a s i cr e s e a r c ho ft h eH B V
life cycle and the mechanism that mediates the early
stages of virus-cell interactions.
Methods
Isolation and culture of human BMSCs
Under a protocol that was approved by the Ethics Com-
mittee of Shandong University, human bone marrow
was aspirated from the iliac crest of healthy donors (18-
36 years) with their informed consent. All donors had
no serologic evidence of hepatitis or previous HBV
infection. The mononuclear cell fraction was separated
via centrifugation using a Ficoll-Paque gradient and
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5 cells/cm
2 in low-glucose DMEM
(Gibco) that was supplemented with 10% FBS (Gibco)
and 100 IU/mL penicillin and 100 mg/mL streptomycin.
The cells were cultured at 37°C in a humidified atmo-
sphere with 50 mL/L CO2 in air. After 3 days, the non-
adherent cell fraction was removed by washing with
PBS. Monolayers of attached cells were cultured until
they reached 70-90% confluence. The cells were pas-
saged five times prior to further analysis to ensure the
removal of contaminating hematopoietic cells.
Flow cytometric analysis
For cell-surface antigen phenotyping, fifth-passage
BMSCs were detached and stained with phycoerythrin
(PE)-conjugated monoclonal antibodies against CD45
and fluorescein isothiocyanate (FITC)-labeled antibodies
against CD34, CD105 and CD90 and analyzed using
flow cytometry with a FACScan (Becton Dickinson,
USA). All antibodies were purchased from Becton Dick-
inson. Isotype control experiments were run in parallel
using the same concentration of each antibody.
Cell lines
The HepG2.2.15 cell line, which is a stable human hepa-
tocellular carcinoma cell line that is permanently trans-
fected with HBV-DNA, was obtained from the China
Center for Type Culture Collection. HepG2.2.15 cells
were cultured with high-glucose DMEM (Gibco) that
was supplemented with 10% FBS, 100 IU/mL penicillin,
100 mg/mL streptomycin, and 380 ng/mL G418 in an
incubator with 95% humidity and 50 mL/L CO2 at 37°C.
HepG2.2.15 cells were used as a positive control.
Infectious serum source
A serum sample for infection was obtained from a hepa-
titis B patient who was positive for HBsAg, HBeAg, and
HBcAb (HBV core antibody) detection and had a HBV
DNA serum load that was 5.4 × 10
8 copies/mL. The
patient had received no antiviral therapy prior to the
study and was not infected with HCV or HIV. The sera
were stored at -80°C until use.
In vitro infection
The fifth generation of BMSCs was seeded in six-well
culture dishes. FBS was omitted from the media for 24
h. The cells were incubated with L-DMEM and 10%
HBV sera concentration. Following 24 h of exposure,
the cells were washed 5 times with PBS to remove the
unabsorbed virus. PBS that was used in the sixth wash
was collected for detection of HBV DNA using PCR.
Thereafter, the cells were cultured with complete media
and the start of this incubation was taken as time zero.
We used one-well of cells without HBV serum as a
negative control.
Analysis for intracellular and extracellular HBV DNA
After infection, aliquots of the BMSCs were harvested
using trypsin at various times and their culture superna-
tants were collected in order. All samples were stored at
-80°C. The total DNA was extracted from harvested
cells and culture medium according to the method
described by Klintschar et al [8]. The HBV PCR fluores-
cent quantitative detection kit (Piji Biotec, Shenzhen,
China) was used according to the manufacturer’s
protocols.
Detection of HBsAg and HBeAg
The HBsAg and HBeAg levels in the media of infected
BMSCs were measured using electrochemiluminescence
(ECL) with the Elecsys 2010 fully-automated ECL analy-
zer (Roche).
Detection of HBcAg in infected BMSCs
Infected and control cells were fixed in 40 g/L parafor-
maldehyde for 20 min at 4°C and permeabilized in Tri-
t o nX - 1 0 0( 0 . 5 %i nP B S ) .A f t e rb l o c k i n gi ng o a ts e r u m
(1:10 dilution in PBS) for 30 min at 37°C, the cells were
incubated overnight at 4°C with a specific mouse mono-
clonal antibody against HBcAg (1:200 dilution) (Milli-
pore). The secondary antibody was a FITC-tagged goat
anti-mouse IgG (1:100 dilution) (SouthernBiotech),
which was incubated with the cells at 37°C for 30 min.
Finally, the cells were incubated for 10 minutes at room
temperature in DAPI (0.5 μg/mL in PBS) and observed
using an inverted fluorescence microscope (Olympus,
Japan). HepG2.2.15 cells were used as a positive control.
BMSCs that were not exposed to HBV were used as a
negative control.
Detection of covalently closed circular DNA (cccDNA)
Episomal DNAs, including HBV cccDNA were extracted
as previously described [9]. Briefly, the cells were lysed
in lysis buffer (50 mM Tris hydrochloride, 10 mM
EDTA, and 1% sodium dodecyl sulfate). The protein-
detergent complexes were precipitated using 2.5 M KCl
(0.25volume). The lysates were shaken and centrifuged
to remove the insoluble material. The supernatant,
which contained viral cccDNA, was used to extract
DNA using an equal volume of phenol. Nucleic acids
were precipitated using 2 volumes of ethanol. Further
purification of cccDNA from contaminating single- and
double-stranded DNA was performed using the method
of Yang [10]. The purified cccDNA samples were sub-
jected to electrophoresis in 1% agarose, transferred to a
nitrocellulose filter, and analyzed by Southern blotting
using a DIG-labeled whole HBV DNA probe. The DIG
High Prime DNA Labeling and Detection Starter Kit I
was purchased from Roche, and the hybridization was
performed according to the manufacturer’s instructions.
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T h ed a t ao fH B VD N A ,H B s A g ,a n dH B e A gw e r e
expressed as mean ± standard deviation (SD). The
results were analyzed using descriptive statistics. The
statistical analysis was performed using SPSS 13.0 statis-
tic software (SPSS Inc., USA).
Results
Characterization of BMSCs
Isolated human bone marrow mononuclear cells were
cultured in growth media. The attached cells were mor-
phologically similar to fibroblasts and exhibited charac-
teristic spindle-shaped fusiform morphology (Figure 1A).
Flow cytometric analysis of the cells from the fifth sub-
culture demonstrated constitutive expression of CD105
(SH2) and CD90, but absence of CD45 and CD34,
which are specific markers to hematopoietic stem cells
(Figure 1D). These results are consistent with the
expression pattern of surface antigens on classical
BMSCs, which has been reported [6,11]. Therefore, we
concluded that the sample of cells that had been cul-
tured consisted solely of BMSCs. After infection,
BMSCs were passaged every 6 days (1:3 dilution) via
trypsinization. There were no obvious differences
between infected BMSCs and uninfected BMSCs (Figure
1B, C). Human BMSCs cultures that were sustained for
10 weeks maintained their characteristic morphology.
Analysis for HBV-DNA in media and cultured cells
The intracellular HBV DNA was first detected at d 2
after infection. Relatively high levels of intracellular HBV
DNA were maintained from d 6 to d 12 (Figure 2A).
HBV DNA was secreted into the culture media from d 3
to d 15, with a secretion peak at d 9 (Figure 2B). Intracel-
lular HBV DNA levels ranged from 4.750 × 10
2 copies/
mL to 9.37 × 10
5 copies/mL, whereas extracellular HBV
DNA levels ranged from 3.792 × 10
2 copies/mL to 4.067
×1 0
5 copies/mL. These DNA molecules were not rem-
nants of the infecting virions because no HBV DNA was
detected in the cells or media at time zero.
Detection of HBsAg and HBeAg
T h ec u l t u r em e d i aw e r ep e r i o dically collected after
infection for ECL analysis of HBsAg and HBeAg levels.
As shown in Figure 3A, HBsAg was detected from d 2
to d 16. The HBsAg levels ranged from 1.612 to 118.100
Figure 1 Characterization of human BMSCs. (A) Morphology of the third generation of human BMSCs under light microscope. (B)
Morphology of the eighth generation of infected human BMSCs under light microscope. (C) Morphology of the eighth generation of uninfected
human BMSCs under light microscope. (D) Analysis by flow cytometry showed that human BMSCs at passage 5 were negative for the expression
of CD34 and CD45, but positive for the expression of CD90 and CD105.
Ma et al. Virology Journal 2011, 8:486
http://www.virologyj.com/content/8/1/486
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appeared positive at d 5, increased until d 10, and
decreased thereafter. The HBeAg levels ranged from
0.115 to 3.407 s/co (absorbance rate/cut-off ratio) (≥1s /
co was considered positive) (Figure 3B). The samples of
culture media from d 0 to d 1 were negative for HBsAg
and HBeAg, indicating that these proteins were synthe-
sized de novo and did not represent input viral antigens
that were present in the inoculum.
Expression of HBcAg
To estimate the percentage of infected human BMSCs,
indirect immunofluorescence was used to assay HBcAg.
HBcAg expression in infected BMSCs was first detected
2 days after infection when approximately 7% of the
cells were stained. Thereafter, the number of cells
expressing HBcAg increased. Approximately 20% of
cells expressed HBcAg at 9 days after infection. As
shown in Figure 4, a diffuse but strong green fluores-
cence was predominantly observed in the cytoplasm of
BMSCs that were infected with HBV but was occasion-
ally observed in their nucleus. By contrast, no HBcAg
was detected in uninfected BMSCs.
HBV cccDNA detection
HBV cccDNA was prepared from the cultured BMSCs
at 2, 4, 6, and 8 days after infection and analyzed using
Southern blotting, when the levels of intracellular HBV-
Figure 2 Analysis of HBV DNA by FQ-PCR. (A) Intracellular HBV DNA was extracted from infected human BMSCs at various times and not
detected until 2 days. (B) Extracellular HBV DNA was extracted from cell supernatants at various times and not detected until 3 days. No HBV
DNA was detected in the cells or supernatants at time zero (data not shown).
Figure 3 Detection of HBsAg and HBeAg using ECL. (A) HBsAg levels in supernatant (≥1 IU/mL was considered positive). (B) HBeAg levels in
supernatant [≥1 s/co (absorbance rate/cut-off ratio) was considered positive].
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slight band of 2.0 kilobases (kb) was observed at d 2 and
corresponded to the expected position for the HBV
cccDNA. Stronger signals were obtained with increasing
time postinfection. To further verify the presence of
cccDNA, the extracted cccDNA sample was digested
using the restriction enzyme EcoRI before loading. After
digestion, the putative cccDNA band shifted to a 3.2-kb
position (Figure 5B), which represents the linear double-
stranded HBV genome. These results unequivocally
show that HBV cccDNA is detected in infected BMSCs.
By comparison, no cccDNA was detected in uninfected
BMSCs.
Discussion
Currently, the hepatoma-derived cell line is a well-estab-
lished and successful system that has been used for the
in vitro study of HBV. However, the viral genome is
introduced by integration or transfection rather than
infection [12,13]. Therefore, these cell lines are unsuita-
b l ef o rs t u d y i n gt h em e c h a n i s mo ft h ee a r l ys t a g e so f
virus-cell interactions, including viral attachment,
penetration, and uncoating. Primary human hepatocytes
allow natural penetration and full viral replication. How-
ever, the use of primary human hepatocytes is hampered
by limited resources and technical difficulties that are
associated with human hepatocyte culture. Treatment of
primary hepatocytes with DMSO or PEG can enhance
and prolong HBV infection [2,3], but these chemicals
may induce artificial mechanisms for viral entry. There-
fore, an ideal cell system for the study of HBV in vitro
is needed. In the present study, an HBV-infected human
BMSCs culture system was established using the method
of co-cultivation of BMSCs with HBV-positive serum in
vitro.
Several methods have been used to isolate BMSCs,
including plastic adherence, gradient density centrifuga-
tion and immunomagnetic selection. The number of
MSCs in the bone marrow is small. There are approxi-
mately 2 to 5 cells that are present in every 1 × 10
6
mononuclear cells [14]. The cells that are selected from
the human bone marrow mononuclear cell fraction by
plastic adherence display typical features of BMSCs [6].
Therefore, we combined the gradient density
Figure 4 Detection of HBcAg using indirect immunofluorescence (×200).( A )H B c A gi ni n f e c t e dh u m a nBMSCs shown by FITC staining
(green color). (B) The cellular nuclei in infected human BMSCs were stained with DAPI (blue color). (C) Overlaid image of images from panels A
and B. (D) HBcAg in HepG2.2.15 cells (positive control) shown by FITC staining. (E) DAPI staining for nuclei of the same field as in panel D. (F)
Overlaid image of images from panels D and E. (G) HBcAg in uninfected human BMSCs (negative control) shown by FITC staining. (H) DAPI
staining for nuclei of the same field as in panel G. (I) Overlaid image of images from panels G and H.
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BMSCs and to obtain abundant and pure BMSCs. In
addition, flow cytometric analysis further confirmed
human BMSCs identity.
In the present study, initial evaluation of the infection
system was performed using quantitative fluorescence
PCR (FQ-PCR) for HBV DNA. Previous studies of bone
marrow cells have provided insufficient information
about the quantitative analysis of HBV-DNA in culture
supernatants and infected cells. FQ-PCR is highly sensi-
tive and permits the use of small amounts of material.
The FQ-PCR method that was used in this study could
detect as few as 10
2 HBV genomes per assay. In our
experiment, the levels of the intracellular and extracellu-
lar HBV-DNA were assayed during the culture period.
No HBV-DNA was detected in the cells or media at
time zero. Therefore, these DNA molecules could not
be carryovers of the infecting virions. Viral DNA in the
medium was not detected until 3 days after infection.
Therefore, the appearance of HBV DNA in the medium
of infected BMSCs was the result of de novo viral gene
product synthesis. In contrast, no HBV-DNA was
detected in uninfected BMSCs. These date indicate that
HBV could infect the cultured human BMSCs and repli-
cate in them in vitro.
In addition to assay of HBV DNA, secretory HBV
antigens were identified using ECL. HBsAg represents a
multi-functional activity that plays a critical role in the
binding of HBV and target cells [15]. The expression of
HBeAg is closely linked to HBV DNA replication [16].
Therefore, our detection of the two HBV-specific anti-
gens provided evidence that replication and expression
of the HBV genome occurred in infected BMSCs. More-
over, the efficiency of HBV infection of BMSCs in vitro,
based on the expression of the HBcAg, was comparable
with the infection of primary human hepatocytes [16]
and human hepatoma cell lines [12,17]. HBcAg forms
the capsid of viral particles and is essential for viral gen-
ome DNA replication. Our results suggest that HBV can
replicate actively in cultured human BMSCs.
In order to provide further supporting evidence that
HBV can infect and replicate in human BMSCs, we ana-
lyzed the intracellular HBV cccDNA via Southern blot
hybridization. In our experiment, intracellular cccDNA
was detected in infected BMSCs as early as 2 days post-
infection. This phenomenon is consistent with the view
that the appearance of cccDNA in the nucleus is one of
the earliest events in the replication of hepadnaviruses
[18]. The cccDNA is thought to be the template for
transcription of mRNAs and pregenome RNA, which for
synthesis of new DNA genomes via reverse transcription
[9]. Therefore, our experimental infection system not
only surports HBV infection but also reproduces the
complete cycle of viral replication. Nevertheless, South-
ern blot analysis of total DNA isolated from BMSCs
failed to demonstrate the presence of the relaxed circu-
lar and single stranded forms of HBV DNA (data not
shown). This was not surprising due to the relatively
low titer of HBV DNA (10
2-10
5 copies/mL) as measured
in the infected BMSCs using FQ-PCR. Similar results in
primary human hepatocytes in vitro have been reported
previously [2]. This may be due to a different host envir-
onment in culture compared to hepatocytes in vivo.
In our study, we also performed reinfection experi-
ments. The progeny virions were infectious (data not
shown). The media of infected BMSCs were incubated
with mouse antibodies directed against HBsAg (anti-
HBsAg). The media were assayed for infectivity using
FQ-PCR and ECL. The anti-HBsAg antibodies reduced
the infectivity (data not shown). These results suggest
that uptake of HBV into BMSCs follows the authentic
Figure 5 Southern blot analysis of HBV cccDNA in infected
human BMSCs. (A) HBV cccDNA was extracted from human BMSCs
at 2, 4, 6, and 8 days after infection and subjected to Southern blot
hybridization. DIG-labeled whole HBV DNA probe served as a
positive control (lane M). Uninfected BMSCs served as a negative
control (lane U). DNA sizes are indicated on the left (kb). (B) The
cccDNA cleaved by EcoRI was analyzed using Southern blot analysis.
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secrete infectious virions into the media.
In our experiment, the infected BMSCs were sustained
for 10 weeks or more and maintained their characteristic
phenotype. As a subset of bone marrow stem cells,
BMSCs are relatively easily separated and grown in cul-
ture. Due to their excellent proliferation capabilities with-
out losing their initial characteristics, they can overcome
the limitations associated with human hepatocyte culture
(e.g., scarce resources and technical difficulties). Previous
studies have indicated that human BMSCs are capable of
differentiating into functional hepatocyte-like cells in
vitro [4,5]. In our studies, we found that HBV could also
infect and replicate in the hepatocyte-like cells induced
from human BMSCs (data not shown). Interestingly,
hepatocyte-like cells from human BMSCs were hard to
maintain in cultures and had poor proliferative potential
in vitro. These features are similar to adult human hepa-
tocytes. The results of our study demonstrate that human
BMSCs display a better advantage over BMSC-derived
hepatocyte-like cells in studies of HBV.
It was reported that HBV could infect and replicate in
bone marrow cells in vivo [19]. As a subset of bone
marrow cells, it remains to be seen whether BMSCs are
permissive for productive HBV replication in vivo. In
addition, it remains unclear if HBV uses the same path-
way/mechanism to infect BMSCs and hepatocytes.
These need to investigate in future studies.
Conclusion
In conclusion, several lines of evidence indicate that the
human BMSCs can maintain HBV infection in vitro and
support the replication of HBV DNA. Our experimental
in vitro infection system will be a powerful tool to ana-
lyze the complex interactions between HBV and its host
cell at the molecular levels and to evaluate different
antiviral strategies. Furthermore, our findings with this
system provide evidence that HBV exhibits a wider host
range than previously reported, and may help explain
HBV reinfection in recipients of liver transplants.
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